GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS

CAUTION: Investigational device. Limited by United States law to investigational use.

Apr 12, 2022

First Patient Enrolled in GORE® TAG® Thoracic Branch Endoprosthesis Early Feasibility Study

First Early Feasibility Study of a Gore Device Will Assess Treatment of Aortic Arch Aneurysms

FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke

Gore REDUCE Clinical Study demonstrated 77 percent relative reduction in recurrent ischemic stroke when PFO closure was combined with antiplatelet therapy, compared to antiplatelet therapy alone

FDA Approves First Balloon Expandable Stent Graft for Use in the Iliac Artery

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Provides Improved Outcomes in Real-World Peripheral Arterial Disease Cases

GORE® EXCLUDER® Iliac Branch Endoprosthesis is First Dedicated System of Its Kind Registered in Australia and New Zealand

First Successful Implants Providing Endovascular Repair to Iliac Arteries Completed in Australia

Gore to Highlight Real-World Aortic Data at 45th Annual VEITHsymposium<sup>&reg;</sup>

Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts

Gore Joins Vascular and Endovascular Leaders in Recognizing the 2014 Pioneers in Performance for North America

Leading Practitioners and Researchers from North America Commended for Commitment to Advancing Vascular and Endovascular Therapy

GORE® EXCLUDER® Conformable AAA Endoprosthesis Obtains CE Mark

Continually expanding clinicians’ options in the endovascular treatment of patients with aortic disease

Gore Launches Clinical Quality Improvement (CQI) Project of New Hernia Repair Device

New research methodology will procure real world feedback from surgeons and patients to improve outcomes with GORE® SYNECOR Biomaterial

Gore Applauds Medicare Announcement to Reclassify Endovascular Abdominal Aneurysm Repairs

Decision comes after two-year effort to improve the alignment of payment with cost of treatment for abdominal aortic aneurysms